Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nile Pharmaceuticals and Chemical Industries is a prominent Egyptian pharmaceutical manufacturer established in 1962 and headquartered in Cairo. As a subsidiary of the state-owned Holding Company for Pharmaceuticals, Chemicals and Medical Supplies (HoldiPharma), the company plays a vital role in providing affordable healthcare solutions to the Egyptian and regional markets. Nile Pharma specializes in the large-scale production of generic medicines across a wide array of therapeutic areas, including cardiology, infectious diseases, and gastroenterology. The company operates extensive manufacturing facilities that are GMP-certified, producing various dosage forms such as tablets, capsules, injectables, and topicals. Publicly traded on the Egyptian Exchange, Nile Pharma continues to expand its export footprint across the Middle East and Africa.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nile Pharmaceuticals and Chemical Industries.